We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Merck & Co Inc (MRK) Common Stock USD0.50

Sell:$125.71 Buy:$125.75 Change: $0.28 (0.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$125.71
Buy:$125.75
Change: $0.28 (0.22%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$125.71
Buy:$125.75
Change: $0.28 (0.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Merck & Co., Inc. is a global health care company. It offers health solutions through its prescription medicines, including biologic therapies, vaccines and animal health products. Its Pharmaceutical segment includes human health pharmaceuticals and vaccine products. Human health pharmaceutical products include therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. Its Animal Health segment discovers, develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products and health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species. Its lead candidate, MK-6070, is a T-cell engager targeting delta-like ligand 3, an inhibitory canonical Notch ligand. Its lead candidate, Restoret, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that acts as an agonist of the Wingless-related integration site signaling pathway.

Contact details

Address:
126 East Lincoln Avenue
RAHWAY
07065
United States
Telephone:
+1 (908) 7404000
Website:
https://www.merck.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MRK
ISIN:
US58933Y1055
Market cap:
$324.50 billion
Shares in issue:
2.53 billion
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
Dow Jones Industrial Average

Key personnel

  • Robert Davis
    Chairman of the Board, President, Chief Executive Officer
  • Betty Larson
    Chief Human Resource Officer
  • David Williams
    Executive Vice President, Chief Information and Digital Officer
  • Jennifer Zachary
    Executive Vice President, General Counsel, Corporate Secretary
  • Sanat Chattopadhyay
    Executive Vice President and President - Merck Manufacturing Division
  • Richard Deluca
    Executive Vice President, President - Merck Animal Health
  • Cristal Downing
    Executive Vice President, Chief Communications and Public Affairs Officer
  • Dean Li
    Executive Vice President, President - Merck Research Laboratories
  • Dalton Smart
    Senior Vice President Finance – Global Controller
  • Chirfi Guindo
    Senior Vice President, Chief Marketing Officer - Human Health

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.